> top > docs > PubMed:23213590 > annotations

PubMed:23213590 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-163 Sentence denotes Transient serotonin syndrome by concurrent use of electroconvulsive therapy and selective serotonin reuptake inhibitor: a case report and review of the literature.
TextSentencer_T2 164-499 Sentence denotes The serotonin syndrome, which is characterized by psychiatric, autonomic nervous and neurological symptoms, is considered to be caused by excessive stimulation of the 5-HT1A and 5-HT2 receptors in the gray matter and spinal cord of the central nervous system, after the start of dosing or increase of the dose of a serotoninergic drug.
TextSentencer_T3 500-640 Sentence denotes There have been hardly any reports of induction of serotonin syndrome by electroconvulsive therapy (ECT) in combination with antidepressant.
TextSentencer_T4 641-828 Sentence denotes We present the case of a female patient with major depressive disorder (MDD) who developed transient serotonin syndrome soon after the first session of ECT in combination with paroxetine.
TextSentencer_T5 829-977 Sentence denotes Paroxetine was discontinued, and her psychiatric, autonomic nervous and neurological symptoms were gradually relieved and disappeared within 2 days.
TextSentencer_T6 978-1176 Sentence denotes We performed the second ECT session 5 days after the initial session and performed 12 sessions of ECT without any changes in the procedure of ECT and anesthesia, but no symptoms of SS were observed.
TextSentencer_T7 1177-1203 Sentence denotes Finally, her MDD remitted.
TextSentencer_T8 1204-1341 Sentence denotes ECT might cause transiently increased blood-brain barrier (BBB) permeability and enhance the transmissivity of the antidepressant in BBB.
TextSentencer_T9 1342-1470 Sentence denotes Therefore, it is necessary to pay attention to rare side effect of serotonin syndrome by ECT in combination with antidepressant.
T1 0-163 Sentence denotes Transient serotonin syndrome by concurrent use of electroconvulsive therapy and selective serotonin reuptake inhibitor: a case report and review of the literature.
T2 164-499 Sentence denotes The serotonin syndrome, which is characterized by psychiatric, autonomic nervous and neurological symptoms, is considered to be caused by excessive stimulation of the 5-HT1A and 5-HT2 receptors in the gray matter and spinal cord of the central nervous system, after the start of dosing or increase of the dose of a serotoninergic drug.
T3 500-640 Sentence denotes There have been hardly any reports of induction of serotonin syndrome by electroconvulsive therapy (ECT) in combination with antidepressant.
T4 641-828 Sentence denotes We present the case of a female patient with major depressive disorder (MDD) who developed transient serotonin syndrome soon after the first session of ECT in combination with paroxetine.
T5 829-977 Sentence denotes Paroxetine was discontinued, and her psychiatric, autonomic nervous and neurological symptoms were gradually relieved and disappeared within 2 days.
T6 978-1176 Sentence denotes We performed the second ECT session 5 days after the initial session and performed 12 sessions of ECT without any changes in the procedure of ECT and anesthesia, but no symptoms of SS were observed.
T7 1177-1203 Sentence denotes Finally, her MDD remitted.
T8 1204-1341 Sentence denotes ECT might cause transiently increased blood-brain barrier (BBB) permeability and enhance the transmissivity of the antidepressant in BBB.
T9 1342-1470 Sentence denotes Therefore, it is necessary to pay attention to rare side effect of serotonin syndrome by ECT in combination with antidepressant.

NEUROSES

Id Subject Object Predicate Lexical cue
T1 0-9 PATO_0002292 denotes Transient
T2 732-741 PATO_0002292 denotes transient
T3 10-19 CHEBI_350546 denotes serotonin
T4 168-177 CHEBI_350546 denotes serotonin
T5 551-560 CHEBI_350546 denotes serotonin
T6 742-751 CHEBI_350546 denotes serotonin
T7 1409-1418 CHEBI_350546 denotes serotonin
T9 168-177 CHEBI_28790 denotes serotonin
T10 551-560 CHEBI_28790 denotes serotonin
T11 742-751 CHEBI_28790 denotes serotonin
T12 1409-1418 CHEBI_28790 denotes serotonin
T14 494-498 CHEBI_23888 denotes drug
T15 625-639 CHEBI_35469 denotes antidepressant
T16 1319-1333 CHEBI_35469 denotes antidepressant
T17 1455-1469 CHEBI_35469 denotes antidepressant
T18 644-651 PATO_0000467 denotes present
T19 666-672 PATO_0000383 denotes female
T20 713-716 CHEBI_566274 denotes MDD
T21 1190-1193 CHEBI_566274 denotes MDD
T22 817-827 CHEBI_7936 denotes paroxetine
T23 829-839 CHEBI_7936 denotes Paroxetine
T24 1232-1241 PATO_0000470 denotes increased
T25 1263-1266 CHEBI_33602 denotes BBB
T26 1337-1340 CHEBI_33602 denotes BBB
T27 1268-1280 PATO_0000970 denotes permeability

Allie

Id Subject Object Predicate Lexical cue
SS1_23213590_2_0 573-598 expanded denotes electroconvulsive therapy
SS2_23213590_2_0 600-603 abbr denotes ECT
SS1_23213590_3_0 686-711 expanded denotes major depressive disorder
SS2_23213590_3_0 713-716 abbr denotes MDD
SS1_23213590_7_0 1242-1261 expanded denotes blood-brain barrier
SS2_23213590_7_0 1263-1266 abbr denotes BBB
AE1_23213590_2_0 SS1_23213590_2_0 SS2_23213590_2_0 abbreviatedTo electroconvulsive therapy,ECT
AE1_23213590_3_0 SS1_23213590_3_0 SS2_23213590_3_0 abbreviatedTo major depressive disorder,MDD
AE1_23213590_7_0 SS1_23213590_7_0 SS2_23213590_7_0 abbreviatedTo blood-brain barrier,BBB

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 692-702 HP_0000716 denotes depressive

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 365-376 http://purl.obolibrary.org/obo/UBERON_0002020 denotes gray matter
PD-UBERON-AE-B_T2 381-392 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord
PD-UBERON-AE-B_T3 400-407 http://purl.obolibrary.org/obo/UBERON_0012131 denotes central
PD-UBERON-AE-B_T4 400-422 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous system
PD-UBERON-AE-B_T5 408-422 http://purl.obolibrary.org/obo/UBERON_0001016 denotes nervous system
PD-UBERON-AE-B_T6 1242-1247 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
PD-UBERON-AE-B_T7 1242-1261 http://purl.obolibrary.org/obo/UBERON_0000120 denotes blood-brain barrier
PD-UBERON-AE-B_T8 1248-1253 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain

PubCasesORDO

Id Subject Object Predicate Lexical cue
AB1 168-186 ORDO:43116 denotes serotonin syndrome
TI1 10-28 ORDO:43116 denotes serotonin syndrome
AB2 551-569 ORDO:43116 denotes serotonin syndrome
AB3 742-760 ORDO:43116 denotes serotonin syndrome
AB4 1409-1427 ORDO:43116 denotes serotonin syndrome

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 1242-1247 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
PD-UBERON-AE-B_T2 365-376 http://purl.obolibrary.org/obo/UBERON_0002020 denotes gray matter
PD-UBERON-AE-B_T3 1248-1253 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain
PD-UBERON-AE-B_T4 400-407 http://purl.obolibrary.org/obo/UBERON_0012131 denotes central
PD-UBERON-AE-B_T5 400-422 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous system
PD-UBERON-AE-B_T6 408-422 http://purl.obolibrary.org/obo/UBERON_0001016 denotes nervous system
PD-UBERON-AE-B_T7 1242-1261 http://purl.obolibrary.org/obo/UBERON_0000120 denotes blood-brain barrier
PD-UBERON-AE-B_T8 381-392 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord